(Q34253639)

31 July 2017

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome (English)

1 reference

31 July 2017

0 references

J C Hassel

1

1 reference

31 July 2017

A Sucker

2

1 reference

31 July 2017

L Edler

3

1 reference

31 July 2017

H Kurzen

4

1 reference

31 July 2017

I Moll

5

1 reference

31 July 2017

C Stresemann

6

1 reference

31 July 2017

K Spieth

7

1 reference

31 July 2017

C Mauch

8

1 reference

31 July 2017

K Rass

9

1 reference

31 July 2017

R Dummer

10

1 reference

31 July 2017

D Schadendorf

11

1 reference

31 July 2017

language of work or name

English

0 references

publication date

24 August 2010

1 reference

British Journal of Cancer

31 July 2017

1 reference

31 July 2017

103

1 reference

31 July 2017

6

1 reference

31 July 2017

820-826

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605796

31 July 2017

0 references

cites work

Chemotherapeutics, chemoresistance and the management of melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

Management of metastatic melanoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

Common variants of DNA repair genes and malignant melanoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

Temozolomide induces senescence but not apoptosis in human melanoma cells.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

MGMT gene silencing and benefit from temozolomide in glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

COBRA: a sensitive and quantitative DNA methylation assay

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group

6 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605796

Phase II study of extended-dose temozolomide in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605796

Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605796

Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605796

Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966614

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

28 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605796

Surgical therapy for distant metastases of malignant melanoma

21 January 2018

1 reference

12 December 2020

Serum DNA as a tool for cancer patient management

1 reference

12 December 2020

Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma

1 reference

12 December 2020

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6605796

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference